TrialCell reports. Medicine2021

Pharmacodynamic effects of direct AMP kinase activation in humans with insulin resistance and non-alcoholic fatty liver disease: A phase 1b study.

Pascale Fouqueray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.